Payment overview · 2025
General Payments
$115.24
2 reported records · 2 companies
Healthcare provider profile · identity verified
Tyler M Buser, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · WICHITA, KS · NPI 1912148776
Verified facts
What the public records show
CMS Open Payments records show Tyler M Buser, M.D. received $115.24 in general payments during 2025 across 2 reported records.
Teva Pharmaceuticals USA, Inc. accounted for 86.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
Teva Pharmaceuticals USA, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported AUSTEDO as an associated drug or biological on 28 records involving 15 distinct recipient NPIs. Public Medicare Part D data also shows 16 claims for Austedo by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | Unresolved — no canonical attribution shown | $99.99 | 86.8% | 1 | 2025 |
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $15.25 | 13.2% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Education | $99.99 | 1 |
| Food and Beverage | $15.25 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $15.25 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. Exact reporting entity; no affiliate inference |
2025 | AUSTEDO open payments reported associated product |
CMS Open Payments — General Payments 28 supporting records · 15 recipient NPIs · example record 1247249192 |
Austedo · 2024 Exact normalized brand match · 1 Part D row |
16 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1272 | 196 |
| Eliquis | Apixaban | 1030 | 114 |
| Levothyroxine Sodium | Levothyroxine Sodium | 878 | 146 |
| Potassium Chloride | Potassium Chloride | 828 | 147 |
| Amlodipine Besylate | Amlodipine Besylate | 652 | 113 |
| Omeprazole | Omeprazole | 554 | 124 |
| Gabapentin | Gabapentin | 491 | 82 |
| Furosemide | Furosemide | 439 | 95 |
| Metoprolol Tartrate | Metoprolol Tartrate | 412 | 80 |
| Bumetanide | Bumetanide | 383 | 65 |
| Mirtazapine | Mirtazapine | 363 | 61 |
| Pantoprazole Sodium | Pantoprazole Sodium | 342 | 57 |
| Tamsulosin Hcl | Tamsulosin Hcl | 339 | 64 |
| Sertraline Hcl | Sertraline Hcl | 335 | 67 |
| Clopidogrel | Clopidogrel Bisulfate | 321 | 56 |
| Losartan Potassium | Losartan Potassium | 314 | 48 |
| Lisinopril | Lisinopril | 308 | 59 |
| Carvedilol | Carvedilol | 303 | 48 |
| Metformin Hcl | Metformin Hcl | 290 | 38 |
| Tradjenta | Linagliptin | 262 | 21 |
| Xarelto | Rivaroxaban | 224 | 17 |
| Trazodone Hcl | Trazodone Hcl | 214 | 41 |
| Buspirone Hcl | Buspirone Hcl | 212 | 38 |
| Escitalopram Oxalate | Escitalopram Oxalate | 211 | 39 |
| Metoprolol Succinate | Metoprolol Succinate | 196 | 38 |
| Amiodarone Hcl | Amiodarone Hcl | 191 | 49 |
| Spironolactone | Spironolactone | 182 | 32 |
| Donepezil Hcl | Donepezil Hcl | 154 | 31 |
| Allopurinol | Allopurinol | 150 | 39 |
| Ondansetron Hcl | Ondansetron Hcl | 148 | 70 |
| Famotidine | Famotidine | 147 | 35 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 142 | 33 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 142 | 32 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 138 | 23 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 135 | 21 |
| Jardiance | Empagliflozin | 124 | 12 |
| Citalopram Hbr | Citalopram Hydrobromide | 123 | 24 |
| Fluticasone Propionate | Fluticasone Propionate | 119 | 36 |
| Diclofenac Sodium | Diclofenac Sodium | 117 | 42 |
| Levetiracetam | Levetiracetam | 117 | 21 |
| Simvastatin | Simvastatin | 111 | 17 |
| Warfarin Sodium | Warfarin Sodium | 111 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 109 | 23 |
| Myrbetriq | Mirabegron | 109 | 13 |
| Baclofen | Baclofen | 107 | 17 |
| Latanoprost | Latanoprost | 107 | 32 |
| Memantine Hcl | Memantine Hcl | 98 | 24 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 97 | 15 |
| Divalproex Sodium | Divalproex Sodium | 90 | 11 |
| Hydralazine Hcl | Hydralazine Hcl | 90 | 22 |
| Alendronate Sodium | Alendronate Sodium | 89 | 18 |
| Montelukast Sodium | Montelukast Sodium | 89 | 11 |
| Finasteride | Finasteride | 87 | 18 |
| Midodrine Hcl | Midodrine Hcl | 84 | 20 |
| Quetiapine Fumarate | Quetiapine Fumarate | 84 | 24 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 82 | 15 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 81 | 16 |
| Lactulose | Lactulose | 76 | 29 |
| Digoxin | Digoxin | 73 | suppressed |
| Metolazone | Metolazone | 73 | 23 |
| Cephalexin | Cephalexin | 71 | 36 |
| Entresto | Sacubitril/Valsartan | 71 | suppressed |
| Olanzapine | Olanzapine | 67 | 13 |
| Farxiga | Dapagliflozin Propanediol | 64 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 63 | 18 |
| Brilinta | Ticagrelor | 60 | suppressed |
| Budesonide | Budesonide | 60 | 13 |
| Januvia | Sitagliptin Phosphate | 60 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 59 | 14 |
| Ezetimibe | Ezetimibe | 59 | suppressed |
| Nystatin | Nystatin | 57 | 39 |
| Ozempic | Semaglutide | 57 | suppressed |
| Prednisone | Prednisone | 57 | 17 |
| Lovastatin | Lovastatin | 55 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 53 | suppressed |
| Torsemide | Torsemide | 53 | 11 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 50 | 12 |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 50 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 50 | suppressed |
| Ondansetron Odt | Ondansetron | 50 | 20 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 49 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 49 | 13 |
| Sucralfate | Sucralfate | 48 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 47 | 11 |
| Hydrochlorothiazide | Hydrochlorothiazide | 46 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 42 | 13 |
| Tizanidine Hcl | Tizanidine Hcl | 42 | suppressed |
| Trulicity | Dulaglutide | 40 | suppressed |
| Bupropion Xl | Bupropion Hcl | 39 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 37 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 36 | 27 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 36 | 19 |
| Pravastatin Sodium | Pravastatin Sodium | 36 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 35 | suppressed |
| Glipizide | Glipizide | 35 | suppressed |
| Hydrocortisone | Hydrocortisone | 35 | 15 |
| Invokana | Canagliflozin | 35 | suppressed |
| Klor-Con 10 | Potassium Chloride | 35 | suppressed |
| Timolol Maleate | Timolol Maleate | 34 | suppressed |
| Gemtesa | Vibegron | 32 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 32 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 32 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 31 | 18 |
| Divalproex Sodium Er | Divalproex Sodium | 31 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 30 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 30 | 17 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 29 | suppressed |
| Methocarbamol | Methocarbamol | 29 | suppressed |
| Novofine Autocover | Pen Needle, Diabetic, Safety | 28 | suppressed |
| Np Thyroid | Thyroid,pork | 28 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 28 | suppressed |
| Anastrozole | Anastrozole | 27 | suppressed |
| Atenolol | Atenolol | 27 | suppressed |
| Linzess | Linaclotide | 27 | suppressed |
| Budesonide Dr | Budesonide | 26 | suppressed |
| Novolog Flexpen | Insulin Aspart | 26 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 26 | suppressed |
| Aripiprazole | Aripiprazole | 25 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 25 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 25 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 25 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 25 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 25 | suppressed |
| Sotalol | Sotalol Hcl | 25 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 24 | suppressed |
| Ibuprofen | Ibuprofen | 24 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 24 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 24 | 21 |
| Calcium Acetate | Calcium Acetate | 23 | suppressed |
| Celecoxib | Celecoxib | 23 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 23 | 13 |
| Fluconazole | Fluconazole | 23 | 19 |
| Nebivolol Hcl | Nebivolol Hcl | 23 | suppressed |
| Scopolamine | Scopolamine | 23 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 22 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 22 | 14 |
| Meclizine Hcl | Meclizine Hcl | 21 | suppressed |
| Meloxicam | Meloxicam | 21 | suppressed |
| Cefdinir | Cefdinir | 20 | 16 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 20 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 20 | suppressed |
| Restasis | Cyclosporine | 20 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 20 | 12 |
| Steglatro | Ertugliflozin Pidolate | 20 | 11 |
| Dorzolamide Hcl | Dorzolamide Hcl | 19 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 19 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 19 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 19 | suppressed |
| Trospium Chloride | Trospium Chloride | 19 | suppressed |
| Colchicine | Colchicine | 18 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 18 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 18 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 18 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 18 | suppressed |
| Primidone | Primidone | 18 | suppressed |
| Amoxicillin | Amoxicillin | 17 | suppressed |
| Estradiol | Estradiol | 17 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 17 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 16 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 16 | 11 |
| Arnuity Ellipta | Fluticasone Furoate | 16 | suppressed |
| Austedo | Deutetrabenazine | 16 | suppressed |
| Topiramate | Topiramate | 16 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 16 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 16 | suppressed |
| Acetic Acid | Acetic Acid | 15 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 15 | 13 |
| Clonidine Hcl | Clonidine Hcl | 15 | suppressed |
| Clozapine | Clozapine | 15 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 15 | suppressed |
| Gemfibrozil | Gemfibrozil | 15 | suppressed |
| Lorazepam | Lorazepam | 15 | suppressed |
| Methimazole | Methimazole | 15 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Acyclovir | Acyclovir | 14 | suppressed |
| Admelog Solostar | Insulin Lispro | 14 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 14 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 14 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 14 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 14 | suppressed |
| Sulfasalazine | Sulfasalazine | 14 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 14 | suppressed |
| Verapamil Er | Verapamil Hcl | 14 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 13 | suppressed |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 13 | suppressed |
| Calcitriol | Calcitriol | 13 | suppressed |
| Carbamazepine | Carbamazepine | 13 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 13 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 13 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 13 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 13 | suppressed |
| Haloperidol | Haloperidol | 13 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 13 | 12 |
| Methotrexate | Methotrexate Sodium | 13 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 13 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 13 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 13 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 13 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Alprazolam | Alprazolam | 12 | suppressed |
| Dexamethasone | Dexamethasone | 12 | suppressed |
| Ertapenem | Ertapenem Sodium | 12 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 12 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 12 | suppressed |
| Imatinib Mesylate | Imatinib Mesylate | 12 | suppressed |
| Irbesartan | Irbesartan | 12 | suppressed |
| Ketoconazole | Ketoconazole | 12 | suppressed |
| Matzim La | Diltiazem Hcl | 12 | suppressed |
| Nitroglycerin | Nitroglycerin | 12 | suppressed |
| Valsartan | Valsartan | 12 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 12 | suppressed |
| Carbamazepine Er | Carbamazepine | 11 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 11 | suppressed |
| Risperidone | Risperidone | 11 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 11 | suppressed |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $115.24 · 2 records | Teva Pharmaceuticals USA, Inc. | INGREZZA | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with Teva Pharmaceuticals USA, Inc.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error